RBMS3, a RNA-binding protein with tumor-suppressing functions, shows reduced expression in epithelial ovarian cancer (EOC), and this decrease is linked to poorer outcomes for patients, such as shorter overall survival and progression-free survival (147). Here, RBMS3 is linked to ovarian carcinoma.